Literature DB >> 7552995

Impaired expansion of mouse B cell progenitors lacking Btk.

J D Kerner1, M W Appleby, R N Mohr, S Chien, D J Rawlings, C R Maliszewski, O N Witte, R M Perlmutter.   

Abstract

Mutations in the gene encoding the protein tyrosine kinase Btk are associated with the human B cell immunodeficiency X-linked agammaglobulinemia (XLA). In the mouse, a point mutation in the Btk pleckstrin homology domain segregates with a milder X-linked immunodeficiency (xid). To assess the importance of Btk function in murine lymphopoiesis, we generated multiple embryonic stem cell clones bearing a targeted disruption of the btk gene and examined their potential to produce lymphocytes in both C57BL/6 and RAG2-/- host chimeric animals. These mice provide a complementary set of in vivo competition assays that formally establish the genetic basis for the xid phenotype. Although the null mutation yields a phenotype quite similar to that of xid, it also compromises expansion of B cell precursors. Our results suggest that the murine and human consequences of Btk deficiency differ only quantitatively, and represent the same disease process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7552995     DOI: 10.1016/1074-7613(95)90115-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  71 in total

Review 1.  Early B cell defects.

Authors:  H B Gaspar; M E Conley
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

2.  Posttranscriptional regulation of Bruton's tyrosine kinase expression in antigen receptor-stimulated splenic B cells.

Authors:  S Nisitani; A B Satterthwaite; K Akashi; I L Weissman; O N Witte; M I Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 3.  X-linked agammaglobulinemia.

Authors:  M E Conley; J Rohrer; Y Minegishi
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

Review 4.  How the immune system works to protect the host from infection: a personal view.

Authors:  C A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

5.  BLNK: molecular scaffolding through 'cis'-mediated organization of signaling proteins.

Authors:  Christopher W Chiu; Mark Dalton; Masamichi Ishiai; Tomohiro Kurosaki; Andrew C Chan
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

6.  Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex.

Authors:  Shiann-Tarng Jou; Nick Carpino; Yutaka Takahashi; Roland Piekorz; Jyh-Rong Chao; Neena Carpino; Demin Wang; James N Ihle
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

7.  A phosphorylation site in Bruton's tyrosine kinase selectively regulates B cell calcium signaling efficiency by altering phospholipase C-gamma activation.

Authors:  Shuling Guo; Gregory Z Ferl; Rajendar Deora; Mireille Riedinger; Sheng Yin; James L Kerwin; Joseph A Loo; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-16       Impact factor: 11.205

8.  Increased numbers of B-1 cells and enhanced responses against TI-2 antigen in mice lacking APS, an adaptor molecule containing PH and SH2 domains.

Authors:  Masanori Iseki; Chiyomi Kubo; Sang-Mo Kwon; Akiko Yamaguchi; Yuki Kataoka; Nobuaki Yoshida; Kiyoshi Takatsu; Satoshi Takaki
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

Review 9.  The B-cell receptor signaling pathway as a therapeutic target in CLL.

Authors:  Jennifer A Woyach; Amy J Johnson; John C Byrd
Journal:  Blood       Date:  2012-06-19       Impact factor: 22.113

10.  Bruton's tyrosine kinase: from X-linked agammaglobulinemia toward targeted therapy for B-cell malignancies.

Authors:  Sabine Ponader; Jan A Burger
Journal:  J Clin Oncol       Date:  2014-04-28       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.